For more information or confidential assistance
se habla español

AbbVie Looking for Further Delay in AndroGel Lawsuits

Presently, there are over 800 AndroGel lawsuits pending against manufacturer AbbVie, all of which are seeking compensation for expenses and damages incurred as a result of alleged side effects linked to the testosterone therapy. These claims, which have been consolidated along with other lesser-known claims against testosterone replacement products, are awaiting... Read more »

FDA to Clarify Position on Off-Label Uses of Drugs

Off-label use of prescription medications, a common practice that healthcare providers have long relied on and that pharmaceutical companies have profited from, has become the subject of a great deal of controversy. Billions in settlements have been paid out to patients who were allegedly harmed as a result of the off-label... Read more »

Research Misconduct Involving Xarelto Goes Unreported

JAMA Internal Medicine recently published a study by Charles Seife that highlights a profound flaw in how consumers obtain information about clinical drug trials. According to the New York University professor, only 4 percent of questionable practices or violations discovered by health regulators during pharmaceutical trials ever reaches the public.... Read more »

New Study Reveals Need for Clinical Clarification of Testosterone Side Effects

For aging men, testosterone replacement therapy can help combat some of the physiological symptoms of decreasing testosterone levels – a condition known as “Low-T.” However, much like female hormone replacement therapy, Low-T treatments have come under increasing scrutiny for potential side effects and unexpected life-threatening ailments in patients receiving therapy... Read more »

Actos Bladder Cancer Lawsuit Filed by Multiple Plaintiffs

Twelve plaintiffs have filed lawsuits against Takeda Pharmaceuticals, claiming the drug caused their spouse or themselves to develop bladder cancer. Each Actos lawsuit will be added to the ongoing multidistrict litigation in the Western District of Louisiana. Actos is an oral diabetes medication used to control blood sugar levels in... Read more »

Deceptive Marketing at Crux of Androgel Lawsuit

The U.S. Food and Drug Administration has yet to approve any type of testosterone replacement therapy as a treatment for age-associated low testosterone levels, otherwise known as “Low T.” Yet manufacturers of testosterone supplements have aggressively marketed products like Androgel to thousands of middle aged American men who believed they... Read more »